[11] described a case of a 30-year-old man on treatment with valproic acid 1000 mg per day who started rivaroxaban 15 mg twice daily for 3 weeks, followed by 20 mg daily for a DVT episode in the context of a heterozygous prothrombin gene mutation. This evidence concerns the gene F2 and deep vein thrombosis.